Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Univariate and multivariate survival analyses for DFS

From: Novel PET imaging biomarkers as predictors of postoperative recurrence in lung adenocarcinoma

Parameter

Univariate analysis

Multivariate analysis

P-value

Hazard ratio (95% CI)

P-value

Hazard ratio (95% CI)

Stage

0.073

1.204 (0.983–1.475)

  

T Stage

0.734

1.060 (0.757–1.485)

  

N Stage

 < 0.05

2.162 (1.426–3.279)

 < 0.05

1.423 (1.018–1.988)

SUVmax

 < 0.05

1.082 (1.022–1.144)

0.131

1.033 (0.990–1.077)

TLG

0.473

1.001 (0.998–1.004)

  

MTV

0.991

1.000 (0.974–1.026)

  

Operation

0.184

1.256 (0.898–1.756)

  

Adjuvant Therapy

0.521

0.792 (0.388–1.615)

  

CEA

0.281

1.008 (0.994–1.022)

  

NHOCmax

0.170

0.486 (0.173–1.364)

  

NHOPmax

 < 0.05

0.079 (0.017–0.360)

 < 0.05

0.399 (0.162–0.979)

  1. CI confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us